CytoDyn Inc.
Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.
Nitya G. Ray, Ph.D., will continue in his role as Chief Technology Officer, but will no longer serve as Chief Operating Officer.
Christopher P. Recknor, M.D., will serve as Senior Director of Research and Development, but will no longer be an executive officer of the Company as defined in the rules of the Securities and Exchange Commission.
Extracted from this filing and checked against the source text.
Nitya G. Ray changed role as Chief Operating Officer at CytoDyn Inc..
Nitya G. Ray, Ph.D., will continue in his role as Chief Technology Officer, but will no longer serve as Chief Operating Officer.View on SEC.gov
Christopher P. Recknor changed role as Senior Director of Research and Development at CytoDyn Inc..
Christopher P. Recknor, M.D., will serve as Senior Director of Research and Development, but will no longer be an executive officer of the Company as defined in the rules of the Securities and Exchange Commission.View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.